Chemical Compound
1-Butanone, 4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl)-; Butyrophenone, 4-[4-(p-chlorophenyl)-4-hydroxypiperidino]-4'-fluoro- (6CI,8CI); 1-(3-p-Fluorobenzoylpropyl)-4-p-chlorophenyl-4-hydroxypiperidine; 4-(4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-1-butanone; 4-(4-Hydroxy-4'-chloro-4-phenylpiperidino)-4'-fluorobutyrophenone; 4-[4-(p-Chlorophenyl)-4-hydroxypiperidino]-4'-fluorobutyrophenone; Aloperidin; Bioperidolo; Brotopon; Dozic; Einalon S; Eukystol; Haldol; Haloperidol; Haloperin; Halosten; Keselan; Linton; McN-JR 1625; NSC 170973; NSC 615296; Neurodol; Peluces; R 1625; Serenace; Serenase; Serenelfi; Sigaperidol; g-[4-(p-Chlorphenyl)-4-hydroxypiperidino]-p-fluorbutyrophenone; g-[4-(p-Chlorphenyl)-4-hydroxypiperidino]-p-fluorbutyrophenone; Haloperidol Decanoate Impurity G
CAS Registry Number
52-86-8
Primary record
1-Butanone, 4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl)-; Butyrophenone, 4-[4-(p-chlorophenyl)-4-hydroxypiperidino]-4'-fluoro- (6CI,8CI); 1-(3-p-Fluorobenzoylpropyl)-4-p-chlorophenyl-4-hydroxypiperidine; 4-(4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-1-butanone; 4-(4-Hydroxy-4'-chloro-4-phenylpiperidino)-4'-fluorobutyrophenone; 4-[4-(p-Chlorophenyl)-4-hydroxypiperidino]-4'-fluorobutyrophenone; Aloperidin; Bioperidolo; Brotopon; Dozic; Einalon S; Eukystol; Haldol; Haloperidol; Haloperin; Halosten; Keselan; Linton; McN-JR 1625; NSC 170973; NSC 615296; Neurodol; Peluces; R 1625; Serenace; Serenase; Serenelfi; Sigaperidol; g-[4-(p-Chlorphenyl)-4-hydroxypiperidino]-p-fluorbutyrophenone; g-[4-(p-Chlorphenyl)-4-hydroxypiperidino]-p-fluorbutyrophenone; Haloperidol Decanoate Impurity G
- 库存
- 6,873 克
- 纯度
- 99.5 %
- CAS
- 52-86-8
化合物标识与属性
- CAS
- 52-86-8
- PubChem CID
- 3559
- SMILES
- C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
- Canonical SMILES
- O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
名称与同义词
- haloperidol
- Serenace
- Haldol
- Aloperidin
- Serenelfi
- Eukystol
- Serenase
- Linton
- Brotopon
- Dozic
- Aloperidol
- Aloperidolo
- Galoperidol
- Halopoidol
- Halojust
- Ulcolind
- Uliolind
- Halopal
- Keselan
- Pernox
- Sernas
- Sernel
- Aldo
- Bioperidolo
- Sigaperidol
- Einalon S
- Vesalium
- Mixidol
- Peluces
- Halosten
- 52-86-8
- Haldol Solutab
- Haloperidolum
- Fortunan
- Lealgin compositum
- Aloperidon
- Halopidol
- Halidol
- Pekuces
- Halol
- haloperin
- Haloperido
- Neurodol
- Peridol
- Picroside III
- Dozix
- Apo-Haloperidol
- Pms Haloperidol
- Novo-Peridol
- Duraperidol
- Youperidol
- Haldol La
- Halomidol
- Lemonamin
- MDMO-PPV
- Suirolin
- Aloperidolo [DCIT]
- Esextin
- Kentace
- Keselen
- Dolpin
- haloperidol-
- Halo
- Aloperidolo [Italian]
- Epoxy resins
- McN-JR-1625
- Resin epoxy
- Gum mastic
- Haldol decanoate
- Fortunan;
- Haloperidol lactate
- Haloperidol RS
- Haloperidol CRS
- Haldol;
- Picroside-III
- Dozic;
- Haloperidol, 1
- Haldol (TN)
- Aloperidin (TN)
- HALOPERIDOL-D4
- C21H23ClFNO2
- Bioperidolo (TN)
- Duraperidol (TN)
- Haloperidol (Haldol)
- Sigaperidol (TN)
- Brotopon (TN)
- Eukystol (TN)
- Halosten (TN)
- Serenace (TN)
- Serenase (TN)
- Haloperidol, powder
- Prestwick_250
- Haloperidol Intensol
- Keselan (TN)
- Peluces (TN)
- Haloperidolum [INN-Latin]
- Phenolic epoxy resin
- Linton (TN)
- Einalon S (TN)
- Dozic (TN)
- CHEMBL54
- PS14 - Haloperidol
- Haloperidol (Standard)
- N-alpha-Boc-L-asparagine
- RefChem:5876
- Spectrum_000861
- Tocris-0931
- starbld0018801
- Opera_ID_446
- Haloperidol (JP15/USP)
- HALOPERIDOL [MI]
- R-1625
- Prestwick0_000115
- Prestwick1_000115
- Prestwick2_000115
- Prestwick3_000115
- Spectrum2_001268
- Spectrum3_000448
- Spectrum4_000570
- Spectrum5_000788
- CCRIS 1630
- HALOPERIDOL [INN]
- HALOPERIDOL [JAN]
- Lopac-H-1512
- DTXSID4034150
- HALOPERIDOL [HSDB]
- HALOPERIDOL [USAN]
- Biomol-NT_000035
- D0D1AL
- GTPL86
- Probes1_000255
- Probes2_000296
- HALOPERIDOL [VANDF]
- HSDB 3093
- UNII-J6292F8L3D
- 4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one
- AC1L1G7K
- HALOPERIDOL DECANOATE
- MLS000028450
- SCHEMBL8264
- CHEBI:5613
- LNEPOXFFQSENCJ-UHFFFAOYSA-N
- HALOPERIDOL [MART.]
- J6292F8L3D
- Lopac0_000583
- MFCD00051423
- Oprea1_509923
- BSPBio_000130
- BSPBio_002096
- DTXCID2014150
- HALOPERIDOL [USP-RS]
- HALOPERIDOL [WHO-DD]
- HALOPERIDOL [WHO-IP]
- KBioGR_000980
- KBioGR_002390
- KBioSS_001341
- KBioSS_002395
- Haloperidol [USAN:INN:BAN:JAN]
- MLS001146904
- BIDD:GT0128
- DivK1c_000654
- NSC 170973
- NSC-170973
- NSC-615296
- SPECTRUM1500325
- EINECS 200-155-6
- R 1625
- SPBio_001236
- SPBio_002069
- McM-JR-1625
- McN-JR 1625
- NSC170973
- AC1Q77Z0
- BPBio1_000144
- BPBio1_001231
- CHEMBL545608
- orb1311010
- Haloperidol (JP15/USP/INN)
- Haloperidol (JP18/USP/INN)
- Haloperidol - Bio-X trade mark
- NSC 615296
- BDBM21398
- ERK5-1H15
- Haloperidol, 1mg/ml in Methanol
- HMS502A16
- KBio1_000654
- KBio2_001341
- KBio2_002390
- KBio2_003909
- KBio2_004958
- KBio2_006477
- KBio2_007526
- KBio3_001316
- KBio3_002869
- LNEPOXFFQSENCJ-UHFFFAOYSA-
- 4-(4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl)-1-(4-fluorophenyl)butan-1-one
- AOB5645
- BRN 0331267
- CID3559
- HALOPERIDOL [ORANGE BOOK]
- MSK7134
- N05AD01
- VESALIUM COMPONENT HALOPERIDOL
- cMAP_000037
- Haloperidol for system suitability
- NINDS_000654
- NSC615296
- 177716-59-5
- AC250
- C21-H23-Cl-F-N-O2
- GLXC-06536
- HALOPERIDOL [EP MONOGRAPH]
- HALOPERIDOL [USP IMPURITY]
- Haloperidol for peak identification
- HMS1568G12
- HMS1920D03
- HMS2089M15
- HMS2091J09
- HMS2095G12
- HMS2234P08
- HMS3261F08
- HMS3370H11
- HMS3657I13
- HMS3712G12
- HMS5080H05
- Pharmakon1600-01500325
- ZINC537822
- HALOPERIDOL [USP MONOGRAPH]
- BCP33202
- Haloperidol [USAN:BAN:INN:JAN]
- Haloperidol 1.0 mg/ml in Methanol
- STR04750
- CAS-52-86-8
- Haloperidol [USAN:USP:INN:BAN:JAN]
- Tox21_110162
- Tox21_300475
- Tox21_500583
- A0H334
- AC-250
- CCG-36042
- CCG-39111
- EBC-03897
- HALOPERIDOLUM [WHO-IP LATIN]
- HY-14538R
- IN1474
- NCGC00015500-10
- NSC757054
- STL417208
- 1-(3-p-Fluorobenzoylpropyl)-4-p-chlorophenyl-4-hydroxypiperidine
- SMR000058303
- AKOS000280660
- Haloperidol for system suitability CRS
- Samarium(III) acetylacetonate xhydrate
- Tox21_110162_1
- AT13670
- CS-1971
- DB00502
- FG32041
- FH23734
- Haloperidol for peak identification CRS
- J1.365J
- LP00583
- NSC-757054
- SDCCGSBI-0050565.P005
- IDI1_000654
- MRF-0000027
- QTL1_000042
- WLN: T6NTJ A3VR DF& DQ DR DG
- 4'-Fluoro-4-(4-(p-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone
- 4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone
- 4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl)-1-butanone
- NCGC00015500-01
- NCGC00015500-02
- NCGC00015500-03
- NCGC00015500-04
- NCGC00015500-05
- NCGC00015500-06
- NCGC00015500-07
- NCGC00015500-08
- NCGC00015500-09
- NCGC00015500-11
- NCGC00015500-12
- NCGC00015500-13
- NCGC00015500-14
- NCGC00015500-15
- NCGC00015500-16
- NCGC00015500-17
- NCGC00015500-19
- NCGC00015500-24
- NCGC00015500-32
- NCGC00016234-01
- NCGC00023875-02
- NCGC00023875-04
- NCGC00023875-05
- NCGC00023875-06
- NCGC00023875-07
- NCGC00023875-08
- NCGC00023875-09
- NCGC00254503-01
- NCGC00261268-01
- S1920
- AC-19691
- AN-41634
- BH166165
- DA-74000
- HY-14538
- LS-48311
- SC-81035
- SY052276
- H 1512
- Poly[2-methoxy-5-(3',7'-dimethyloctyloxy)-1,4-phenylenevinylene]
- SBI-0050565.P004
- 4-(4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-1-butanone
- AB2000375
- Haloperidol decanoate impurity, haloperidol-
- SC 170973
- TR-018722
- 4-(4-(p-Chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone
- 4-(4-Hydroxy-4'-chloro-4-phenylpiperidino)-4'-fluorobutyrophenone
- AB00052008
- B2099
- EU-0100583
- FT-0669100
- FT-0669101
- FT-0697842
- H0912
- N1910
- NS00010402
- ST50319916
- SW196557-4
- W0039
- 5-21-02-00377 (Beilstein Handbook Reference)
- 4'-Fluoro-4-(4-hydroxy-4-p-chlorophenylpiperidino)butyrophenone
- 4763-EP2269989A1
- 4763-EP2269990A1
- 4763-EP2272537A2
- 4763-EP2272972A1
- 4763-EP2272973A1
- 4763-EP2275420A1
- 4763-EP2277872A1
- 4763-EP2277876A1
- 4763-EP2292614A1
- 4763-EP2295061A1
- 4763-EP2295412A1
- 4763-EP2295413A1
- 4763-EP2295439A1
- 4763-EP2298731A1
- 4763-EP2298776A1
- 4763-EP2305260A1
- 4763-EP2308867A2
- 4763-EP2308870A2
- 4763-EP2311801A1
- 4763-EP2311803A1
- 4763-EP2311824A1
- 4763-EP2311837A1
- 4763-EP2316834A1
- A10446
- C01814
- D00136
- H55351
- M04089
- VU0239704-10
- 1-Butanone, 4-(4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-
- 4-(4-(para-Chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone
- 64438-53-5
- AB00052008-21
- AB00052008-22
- AB00052008_23
- AB00052008_24
- gamma-(4-(p-Chlorophenyl)-4-hydroxypiperidino)-p-fluorbutyrophenone
- gamma-(4-(p-Chlorophenyl)-4-hydroxypiperidino)-p-fluorobutyrophenone
- Haloperidol; Haloperidol Decanoate EP Impurity G
- A899749
- Butyrophenone, 4'-fluoro-4-(4-(p-chlorophenyl)-4-hydroxypiperidino)-
- Butyrophenone, 4-(4-(p-chlorophenyl)-4-hydroxypiperidino)-4'-fluoro-
- L000288
- Q251347
- SR-01000003076
- 1-Butanone, 4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl)-
- 4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)butan-1-one
- 4-[4-(p-Chlorophenyl)-4-hydroxypiperidino]-4'-fluorobutyrophenone
- gamma-(4-(p-Chlorophenyl)-4-hydroxpiperidino)-p-fluorbutyrophenone
- SR-01000003076-2
- SR-01000003076-8
- BRD-K67783091-001-04-8
- BRD-K67783091-001-05-5
- BRD-K67783091-001-25-3
- BRD-K67783091-001-26-1
- BRD-K67783091-003-03-6
- BRD-K67783091-003-07-7
- HALOPERIDOL DECANOATE IMPURITY G [EP IMPURITY]
- I14-13404
- I14-14165
- SR-01000003076-11
- 4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one
- 5,6-Dimethoxy-2-(pyridine-4-yl)methylene-indan-1-one
- 61788-97-4
- 64461-95-6
- Z1590789254
- 4-[4-(4-Chlorophenyl)-4-hydroxypiperidino]-4'-fluorobutyrophenone
- Butyrophenone, 4-[4-(p-chlorophenyl)-4-hydroxypiperidino]-4'-fluoro-
- Haloperidol, European Pharmacopoeia (EP) Reference Standard
- 1189986-59-1
- Poly[[2-[(3,7-dimethyloctyl)oxy]-5-methoxy-1,4-phenylene]-1,2-ethenediyl]
- Poly[2-methoxy-5-(3,7-dimethyoctyoxyl)-1,4-phenylenevinylene]
- .gamma.-[4-(p-Chlorphenyl)-4-hydroxpiperidino]-p-fluorbutyrophenone
- 1-(3-p-Fluorobenzoylpropil)-4-p-clorofenil-4-hidroxipiperidine 4
- 4'-Fluoro-4-[4-hydroxy-4-(4'-chlorophenyl)piperidino]butyrophenone
- 4-(p-Chlorophenyl)-1-[3-(p-fluorobenzoyl)propyl]piperidin-4-ol
- Aloperidin;Bioperidolo;Brotopon;Dozic;Duraperidol;Einalon S;Haldol
- gamma-[4-(p-chlorophenyl)-4-hydroxypiperidino]-p-fluorobutyrophenone
- gamma-[4-(p-Chlorphenyl)-4-hydroxypiperidino]-p-fluorbutyrophenone
- HALOPERIDOL DECANOATE IMPURITY, HALOPERIDOL- [USP IMPURITY]
- Haloperidol, United States Pharmacopeia (USP) Reference Standard
- Poly[2-methoxy-5-(3,7-dimethyloctyloxy)-1,4-phenylenevinylene]
- .gamma.-(4-(p-Chlorophenyl)-4-hydroxpiperidino)-p-fluorbutyrophenone
- 4 -Fluoro-gamma-[4-(p-chlorophenyl)-4-hydroxypiperidino]butyrophenone
- 4-(4-Hydroxy-4''''-chloro-4-phenylpiperidino)-4''''-fluorobutyrophenone
- 4-[4-(4-chlorophenyl)-4-hydroxypiperidyl]-1-(4-fluorophenyl)butan-1-one
- 4-[4-(p-Chlorophenyl)-4-hydroxypiperidino]-4''''-fluorobutyrophenone
- 4-[4-(para-Chlorophenyl)-4-hydroxypiperidino]-4'-fluorobutyrophenone
- Butirofenona, 4-[4-(p-clorofenil)-4-] hidroxipiperidino-4'-fluoro-
- gamma-[4-(4-Chlorophenyl)-4-hydroxypiperidino]-4 -fluorobutyrophenone
- gamma-[4-(p-Chlorophenyl)-4-hydroxypiperidino]-4 -fluorobutyrophenone
- Haloperidol, Pharmaceutical Secondary Standard; Certified Reference Material
- 1-butanona, 4-[4-(4-clorofenil)-4-hidroxi-1-piperidinil]-1-(4-fluorofenil)-
- 1-Butanone, 4-[4-(4-chlorophenyl)-4-hydroxy- 1-piperidinyl]-1-(4-fluorophenyl)-
- 4-(4-(4-chlorophenyl)-4-hydroxy-1-piperidyl)-1-(4-fluorophenyl)-butan-1-one
- 4-[4-(4-Chlorophenyl)-4-hydroxy- 1-piperidinyl]-1-(4-fluorophenyl)- 1-butanone
- 4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl) -1-butanone
- 4-[4-(4-Chlorophenyl)-4-hydroxypiperidin-1-yl]-1-(4-?uorophenyl)butan-1-one
- Butyrophenone 4-[4-(p-chlorophenyl)-4-hydroxypiperidino]-4'-fluoro-(6CI8CI)
- gamma-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl]-4 -fluorobutyrophenone
- Haloperidol for peak identification, European Pharmacopoeia (EP) Reference Standard
- Haloperidol for system suitability, European Pharmacopoeia (EP) Reference Standard
- Haloperidol solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material
- 1-Butanone, 4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl)-; Butyrophenone, 4-[4-(p-chlorophenyl)-4-hydroxypiperidino]-4'-fluoro- (6CI,8CI); 1-(3-p-Fluorobenzoylpropyl)-4-p-chlorophenyl-4-hydroxypiperidine; 4-(4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-1-butanone; 4-(4-Hydroxy-4'-chloro-4-phenylpiperidino)-4'-fluorobutyrophenone; 4-[4-(p-Chlorophenyl)-4-hydroxypiperidino]-4'-fluorobutyrophenone; Aloperidin; Bioperidolo; Brotopon; Dozic; Einalon S; Eukystol; Haldol; Haloperidol; Haloperin; Halosten; Keselan; Linton; McN-JR 1625; NSC 170973; NSC 615296; Neurodol; Peluces; R 1625; Serenace; Serenase; Serenelfi; Sigaperidol; g-[4-(p-Chlorphenyl)-4-hydroxypiperidino]-p-fluorbutyrophenone; g-[4-(p-Chlorphenyl)-4-hydroxypiperidino]-p-fluorbutyrophenone; Haloperidol Decanoate Impurity G
- 1511-16-6
- 200-155-6
- 4-[4-(4-chloro-2,3,5,6-tetradeuteriophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one
- 4-[4-(4-Chloro-phenyl)-4-hydroxy-piperidin-1-yl]-1-(4-fluoro-phenyl)-butan-1-one;propionate(HCl)
- 61789-92-2
- GMJ
- InChI=1/C21H23ClFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2
- Poly[2-methoxy-5-(3 inverted exclamation marka,7 inverted exclamation marka-dimethyloctyloxy)-1,4-phenylenevinylene]
- Poly[2-methoxy-5-(3,7-dimethyloctyloxy) phenylenevinylene-1,4-diyl], Mw 100,000-1000,000 by GPC